This hypothesis was further validated by in vivo experiments using a mouse xenograft tumor model that supported MARCKSL1-2 overexpression leading to attenuated docetaxel resistance in lung adenocarcinoma tumors. The gene discussed is MARCKSL1; the disease is lung adenocarcinoma.